In addition to the genetic mutations of
2019-07-05

In addition to the genetic mutations of α-synuclein and LRRK2, an increasing body of evidence suggests that posttranslational modifications (PTMs) are also critically involved in PD pathogenesis [4,5] (Fig. 1). While PTMs serve to facilitate the normal functions of α-synuclein and LRRK2 in the healt